comparemela.com

Latest Breaking News On - Mahatma gandhi mission medical college hospital - Page 1 : comparemela.com

NanoViricides successfully concludes first-in-human study

NanoViricides successfully concludes first-in-human study
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Safety in Multiple-Ascending-Dose Healthy Subjects Clinical Trial Part Successfully Established for the NanoViricides Ultra-Broad-Spectrum Antiviral Drug NV-CoV-2 with No Adverse Events Found

Safety in Multiple-Ascending-Dose Healthy Subjects Clinical Trial Part Successfully Established for the NanoViricides Ultra-Broad-Spectrum Antiviral Drug NV-CoV-2 with No Adverse Events Found
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Safety in Multiple-Ascending-Dose Healthy Subjects Clinical Trial Part Successfully Established for the NanoViricides Ultra-Broad-Spectrum Antiviral Drug NV-CoV-2 with No Adverse Events Found

NanoViricides, Inc. (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, reported today that the healthy subjects part of the Phase 1a/1b Clinical Trial of NV-CoV-2.

MGC Pharmaceuticals Ltd s historic March quarter highlighted by LSE listing and record sales

MGC Pharmaceuticals’ “historic” March quarter highlighted by LSE listing and record sales MGC Pharma became the first medicinal cannabis company to list on the London Stock Exchange, amid record sales of its phytomedicines. CEO Roby Zomer says the company is now ready to capitalise on years of hard work. MGC Pharmaceuticals Ltd (ASX:MXC) (LON:MXC) (OTCMKTS:MGCLF) (FRA:H5O) has completed arguably its best-ever quarter, with a London Stock Exchange (LSE) listing and record sales highlighting a busy period. The European-based biopharma company, developing and producing phytocannabinoid-derived medicines, released its March quarterly report this morning. It also gained Ethics Committee approval for a Phase III trial to evaluate the efficacy and safety of its COVID-19 drug, CimetrA™, expanded its pre-clinical brain cancer study and locked in additional funding.

MGC Pharmaceuticals Ltd poised to supply global phytocannabinoid market with growing patient base and global distribution footprint

MGC Pharmaceuticals Ltd poised to supply global phytocannabinoid market with growing patient base and global distribution footprint
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.